Unither Pharmaceuticals

Unither Pharmaceuticals is expanding its Amiens site with a production unit dedicated to Euroject and injectable vaccines, aiming for over one billion doses per year with five filling lines.

Unither Pharmaceuticals and Needle Concept announced a strategic partnership to develop a new generation of needles compatible with the Euroject system for single-dose injection.

Marinomed Biotech AG signed an agreement to sell its Carragelose business to Unither Pharmaceuticals for up to EUR 20 million, including upfront and milestone payments, subject to regulatory and shareholder approvals.